Stock RXRX RECURSION PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Recursion Pharmaceuticals, Inc.

Equities

RXRX

US75629V1044

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-26 pm EDT 		5-day change 1st Jan Change
8.12 USD +3.57% Intraday chart for Recursion Pharmaceuticals, Inc. +10.48% -17.65%
Apr. 18 Recursion Pharmaceuticals Insider Sold Shares Worth $367,007, According to a Recent SEC Filing MT
Apr. 16 Recursion Pharmaceuticals Names Najat Khan Chief R&D Officer MT

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Recursion Appoints Najat Khan, PhD, as Chief R&D Officer and Chief Commercial Officer
GL
Recursion Appoints Najat Khan, PhD, as Chief R&D Officer and Chief Commercial Officer
AQ
Recursion to Participate in Upcoming Investor Conference
GL
Recursion to Participate in Upcoming Investor Conference
AQ
Recursion Publishes Annual Environmental, Social and Governance Report
GL
Recursion Announces Plans to Open New Office in London
GL
Recursion Announces Plans to Open New Office in London
AQ
Recursion Hosts Second Annual Rare Disease Day Events for Utah’s Rare Disease Community
GL
Recursion Hosts Second Annual Rare Disease Day Events for Utah’s Rare Disease Community
AQ
Recursion to Participate in Upcoming Investor Conferences
GL
Recursion to Participate in Upcoming Investor Conferences
AQ
Recursion Pharmaceuticals: Q4 Earnings Snapshot
AQ
Recursion Provides Business Updates and Reports Fourth Quarter and Fiscal Year 2023 Financial Results
GL
Recursion to Host Public L(earnings) Call on February 27
GL
Recursion to Host Public L(earnings) Call on February 27
AQ
Thinking about buying stock in BioNexus Gene Lab, Gladstone Investment Corp, Canopy Growth Corp, Recursion Pharmaceuticals, or Monolithic Power Systems?
PR
Altitude Lab Startups Raise Over $120M in Capital
GL
Altitude Lab Startups Raise Over $120M in Capital
AQ
Recursion Unveils LOWE Drug Discovery Software at the J.P. Morgan Healthcare Conference
GL
Recursion Unveils LOWE Drug Discovery Software at the J.P. Morgan Healthcare Conference
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. RXRX Stock
  4. News Recursion Pharmaceuticals, Inc.
  5. Press Releases